Diaphorina citri psyllid: psy17934


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580----
MTPEQLTQYTSPPPTLPSTEGSGDSPSSLSNGDLDTELTLDIKSVRRAYEQLFALPSSEFEHTLVQALVTLSEYINVQLRCGSSLLSTDSLINVFLVIFEIPSLGGCDYVERALPKICKAASQLPLTAQARIARIWAAHCKQRLKTILEALQQLITIKTISNHYHKDYILQDEETITLPTKIMRILFYANILAGDLDPPCLRDETQDPEDNHESMFGVDISSSKSSVQANHYEDSLAKLLQINVLDSRKPLIPFLEFYNEPLSDAIEMDRDFGYYRASEELTSETDCASSSRFLKFSFMYYSFILTPATKTLGLYYDSRIRMYSGRRISYLQSVVGQPTNPYLRLKVRRDHIIEDALVELEMIAMENEKDLKKQLVVEFEGEQGIDEGGVSKEFFQLIIEEIFNPDYGMFCVQSDTQHMWFNQMSFESDAQFTLVGIILGLAIYNNIILDVNFPMVVYKKLMGKRGSFYDLEDFNPVLFNGLRDLLDYEGQDMEDVFSQTFRICFTDPFGAFISHDLKPDGDNIAVTQENKQEFIDLYSDFLLNTSIEKQFKAFRRGFQMVTDESPLSLLFRPEEIEQLVCGSN
ccHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHcccccccccccccEEEEEEccccccccccHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHEEccccccccccccccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccECcccccHHHccHHHHHHHHccccccccccccccccccCEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEcccHHHHHHHHHHHHHcccHHHccccEEEEEccccccccccHHHHHHHHHHHHHcccccccEEEcccccEEEccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccccccEEEEEEEccccccCEEccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHcccc
*************************************LTLDIKSVRRAYEQLFALPSSEFEHTLVQALVTLSEYINVQLRCGSSLLSTDSLINVFLVIFEIPSLGGCDYVERALPKICKAASQLPLTAQARIARIWAAHCKQRLKTILEALQQLITIKTISNHYHKDYILQDEETITLPTKIMRILFYANILAGDLDP***************************SVQANHYEDSLAKLLQINVLDSRKPLIPFLEFYNEPLSDAIEMDRDFGYYRASEE***********RFLKFSFMYYSFILTPATKTLGLYYDSRIRMYSGRRISYLQSVVGQPTNPYLRLKVRRDHIIEDALVELEMIAMENEKDLKKQLVVEFEGEQGIDEGGVSKEFFQLIIEEIFNPDYGMFCVQSDTQHMWFNQMSFESDAQFTLVGIILGLAIYNNIILDVNFPMVVYKKLMGKRGSFYDLEDFNPVLFNGLRDLLDYEGQDMEDVFSQTFRICFTDPFGAFISHDLKPDGDNIAVTQENKQEFIDLYSDFLLNTSIEKQFKAFRRGFQMVTDESPLSLLFRPEEIEQLVCGS*
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MTPEQLTQYTSPPPTLPSTEGSGDSPSSLSNGDLDTELTLDIKSVRRAYEQLFALPSSEFEHTLVQALVTLSEYINVQLRCGSSLLSTDSLINVFLVIFEIPSLGGCDYVERALPKICKAASQLPLTAQARIARIWAAHCKQRLKTILEALQQLITIKTISNHYHKDYILQDEETITLPTKIMRILFYANILAGDLDPPCLRDETQDPEDNHESMFGVDISSSKSSVQANHYEDSLAKLLQINVLDSRKPLIPFLEFYNEPLSDAIEMDRDFGYYRASEELTSETDCASSSRFLKFSFMYYSFILTPATKTLGLYYDSRIRMYSGRRISYLQSVVGQPTNPYLRLKVRRDHIIEDALVELEMIAMENEKDLKKQLVVEFEGEQGIDEGGVSKEFFQLIIEEIFNPDYGMFCVQSDTQHMWFNQMSFESDAQFTLVGIILGLAIYNNIILDVNFPMVVYKKLMGKRGSFYDLEDFNPVLFNGLRDLLDYEGQDMEDVFSQTFRICFTDPFGAFISHDLKPDGDNIAVTQENKQEFIDLYSDFLLNTSIEKQFKAFRRGFQMVTDESPLSLLFRPEEIEQLVCGSN

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Ubiquitin-protein ligase E3A E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. Several substrates have been identified including the RAD23A and RAD23B, MCM7 (which is involved in DNA replication), annexin A1, the PML tumor suppressor, and the cell cycle regulator CDKN1B. Additionally, may function as a cellular quality control ubiquitin ligase by helping the degradation of the cytoplasmic misfolded proteins. Finally, UBE3A also promotes its own degradation in vivo.confidentQ05086
Ubiquitin-protein ligase E3A E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. Several substrates have been identified including the RAD23A and RAD23B, MCM7 (which is involved in DNA replication), annexin A1, the PML tumor suppressor, and the cell cycle regulator CDKN1B. Additionally, may function as a cellular quality control ubiquitin ligase by helping the degradation of the cytoplasmic misfolded proteins. Finally, UBE3A also promotes its own degradation in vivo.confidentO08759

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0070936 [BP]protein K48-linked ubiquitinationprobableGO:0071704, GO:0044267, GO:0044238, GO:0044260, GO:0032446, GO:0019538, GO:0009987, GO:0070647, GO:0006464, GO:0043170, GO:0016567, GO:0043412, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0000209
GO:0004842 [MF]ubiquitin-protein ligase activityprobableGO:0019787, GO:0016879, GO:0016881, GO:0003824, GO:0003674, GO:0016874
GO:0043234 [CC]protein complexprobableGO:0005575, GO:0032991
GO:0005829 [CC]cytosolprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0014068 [BP]positive regulation of phosphatidylinositol 3-kinase cascadeprobableGO:0010646, GO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0014066, GO:0050789, GO:0048522
GO:0005515 [MF]protein bindingprobableGO:0003674, GO:0005488
GO:0042787 [BP]protein ubiquitination involved in ubiquitin-dependent protein catabolic processprobableGO:0044248, GO:0043632, GO:0044267, GO:1901575, GO:0044265, GO:0044260, GO:0071704, GO:0070647, GO:0032446, GO:0006508, GO:0044238, GO:0009987, GO:0019941, GO:0006464, GO:0043412, GO:0036211, GO:0008150, GO:0030163, GO:0008152, GO:0044257, GO:0009056, GO:0009057, GO:0051603, GO:0019538, GO:0044237, GO:0043170, GO:0016567, GO:0006511
GO:0007420 [BP]brain developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0044446 [CC]intracellular organelle partprobableGO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043226, GO:0044422
GO:0003713 [MF]transcription coactivator activityprobableGO:0003674, GO:0003712, GO:0000989, GO:0000988
GO:0005634 [CC]nucleusprobableGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0060736 [BP]prostate gland growthprobableGO:0032502, GO:0044707, GO:0048608, GO:0040007, GO:0048589, GO:0022414, GO:0061458, GO:0032501, GO:0048856, GO:0044767, GO:0003006, GO:0030850, GO:0048513, GO:0008150, GO:0001655, GO:0048731, GO:0048732, GO:0007275, GO:0044699, GO:0000003
GO:0005794 [CC]Golgi apparatusprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0001541 [BP]ovarian follicle developmentprobableGO:0022602, GO:0061458, GO:0008585, GO:0048608, GO:0007275, GO:0044699, GO:0000003, GO:0008406, GO:0045137, GO:0048511, GO:0048513, GO:0032502, GO:0032501, GO:0046545, GO:0048609, GO:0032504, GO:0044767, GO:0022414, GO:0008150, GO:0046660, GO:0007548, GO:0044702, GO:0044707, GO:0003006, GO:0048856, GO:0042698, GO:0048731
GO:0035037 [BP]sperm entryprobableGO:0048610, GO:0006897, GO:0016192, GO:0006810, GO:0009566, GO:0019953, GO:0022414, GO:0044765, GO:0044702, GO:0008150, GO:0007338, GO:0009987, GO:0051234, GO:0051179, GO:0044699, GO:0000003
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0030521 [BP]androgen receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0030518, GO:0007154, GO:0050789, GO:0044699
GO:0005886 [CC]plasma membraneprobableGO:0005575, GO:0044464, GO:0016020, GO:0071944, GO:0005623

Prediction of Enzyme Commission Number ?

No confident prediction of EC number!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 1C4Z, chain A
Confidence level:very confident
Coverage over the Query: 340-584
View the alignment between query and template
View the model in PyMOL
Template: 2ONI, chain A
Confidence level:very confident
Coverage over the Query: 299-318,332-584
View the alignment between query and template
View the model in PyMOL